Explore more publications!

Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

Press releases published on December 17, 2025

SEALSQ Announces WECAN Secures a Grant from Hedera
Renewal Fuels, Inc. Announces Execution of Transformative Merger with Kepler Fusion Technologies
Myseum Debuts ‘Picture Party by Myseum’ Social Media Platform with iOS Beta Launch
OSpark.ai Launches All-Round Free AI Assistant That Unifies Search, Summaries, and Creation in One App
Skygauge Robotics Appoints Tech Veteran Richard Shatilla as CEO to Drive Global Commercial Expansion
Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
Enecom, Inc., a Japanese ICT Services Provider, Enhances Its Enterprise Data Infrastructure with the InfiniBox® Solution for 100% Availability and Cyber Resilient Storage
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 
Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap® 150 Rollout
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
Xeronum Emerges to Power the Next Wave of Digital Experiences
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions